Medco Weighing Opportunities For Consolidation In PBM Space – CEO Snow
This article was originally published in The Pink Sheet Daily
Executive Summary
Acquiring an in-house pharmacy benefit manager from a health plan “could be the right thing for Medco” if done at the “right price,” he says.
You may also be interested in...
Express Scripts Purchase Deal For NextRx Includes 10-Year PBM Contract With WellPoint
With the acquisition of the largest plan-owned pharmacy benefit manager, Express Scripts will move to second place among the big stand-alone PBMs, ahead of CVS Caremark.
Merck’s Winrevair Well Positioned To Benefit From Medicare Part D Redesign
Significant cost sharing reductions under the redesign will enhance uptake of the pulmonary arterial hypertension drug. The trade-off is a 20% mandatory price discount in the catastrophic phase.
Biden vs Trump On Drug Pricing And Unfinished Business
While more significant reforms are less likely under a second Biden term unless Democrats control both chambers of Congress, former President Trump could look to put his stamp on drug pricing reform by resurrecting one of his former policies involving international reference pricing and Medicare Part B drugs.